Cetera Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-18,155
Closed -$295K 1364
2022
Q1
$295K Buy
+18,155
New +$295K 0.01% 1112